Protective effects of hydroxysafflor yellow a on acute and chronic congestive cardiac failure mediated by reducing ET-1, NOS and oxidative stress in rats

Journal of Pharmacy and Pharmacology

Volumn 60, Issue 1, 2008, Pages 115-123

  He, Haibo ^a   Yang, Xianzhe ^a   Shi, Mengqiong ^b   Zeng, Xiaowei ^a   Yang, Jun ^a   Wu, Limao ^a   Li, Anda ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b Center of Medical Science Analysis   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ATRIAL NATRIURETIC FACTOR; CREATINE KINASE; DILTIAZEM; ENDOTHELIN 1; HERBACEOUS AGENT; HYDROXYSAFFLOR YELLOW A; INDUCIBLE NITRIC OXIDE SYNTHASE; LACTATE DEHYDROGENASE; MALONALDEHYDE; NITRIC OXIDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD VISCOSITY; BODY WEIGHT; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; CREATINE KINASE BLOOD LEVEL; DRUG EFFECT; ELECTROCARDIOGRAPHY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; HEART FUNCTION; HEART HEMODYNAMICS; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE WALL; HEART PERFORMANCE; HEART PROTECTION; HEART VENTRICLE REMODELING; HEART WEIGHT; KIDNEY MASS; LACTATE DEHYDROGENASE BLOOD LEVEL; LUNG WEIGHT; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; SHAM PROCEDURE;

ACUTE DISEASE; ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BLOOD VISCOSITY; CARDIOTONIC AGENTS; CHALCONE; CHRONIC DISEASE; CORONARY VESSELS; CREATINE KINASE; DILTIAZEM; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; ENDOTHELIN-1; HEART FAILURE; HEMODYNAMICS; L-LACTATE DEHYDROGENASE; LIGATION; MALONDIALDEHYDE; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; QUINONES; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE;

EID: 38349169370     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.60.1.0015     Document Type: Article

References (46)

1. An, X. Q., Li, Y. H., Chen, J. (1990) Separation and identification of safflor yellow A and carthamin from Carthamus tinctorius L. Chin. Tradit. Herb Drugs 21: 188-189
2. Chen, D. B. (2005) Protective effects and mechanism of safflor yellow A on coronary flux and hemodynamics in acute myocardial ischemia. Lishizhen Med. Mater. Medica Res. 16: 828-830
3. Chen, D. B., Zhao, H., Zhang, L., Zhang, M. F. (2006) Effects of safflor yellow A on myocardial apoptosis induced to ischemia reperfusion in rats. Res. Pract. Chin. Med. 19: 24-26
4. Chris, M. T. (2001) Mediators of chronic heart failure: how drugs work. Ann. Pharmacother. 35: 1066-1074
5. Dai, D. Z., Zong, J. G., Lei, H. Y., Bai, M. Q., Rong, P. (1995) Changes of superoxide dismutase, malondialdehyde, creatine Phosphokinase in non-infarcted zone of an infarcted heart in rats and drug treatment. J. Chin. Pharmaceut. Univ. 26: 291-296
6. Ding, S. S., Qiu, C. B., Hess, P., Xi, J. F., Clozel, J. P., Clozel, M. (2002) Chronic endothelin receptor blockade prevents renal vasoconstrction and sodium retention in rats with chronic heart failure. Cardiovasc. Res. 53: 963-970
7. Fukuchi, M., Hussain, S. N. A., Giaid, A. (1998) Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure: their relation to lesion site and β-adrenergic receptor therapy. Circulation 98: 132-139
8. Gao, G. M., Cui, Z. M. (1990) Pharmacological studies on safflower yellow A. Chin. Tradit. Herb Drugs 21: 188-190
9. Hare, J. M., Givertz, M., Creager, M. A., Colucci, W. S. (1998) Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure: potentiation of β-adrenergic inotropic responsiveness. Circulation 97:161-166
10. He, H. B., Yu, F., Dai, D. Z., Dai, Y. (2007) Down-regulation of FKBP12. 6 and SERCA2a contributes to acute heart failure in septic shock and is related to an up-regulated endothelin signaling pathway. J. Pharm. Pharmacol. 59: 977-984
11. Jay, N. C., Roberto, F., Norman, S. (2000) Cardiac remodeling: concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J. Am. Coll. Cardiol. 35: 569-582
12. Jin, M., Li, J. R., Wu, W. (2004) Study on the antioxidative effect of safflor yellow. China J. Chin. Materia Medica 29: 447-449
13. Jin, M., Li, J. R., Wu, W. (2006) Study on the antioxidation of hydroxysafflor yellow A. Chin. Trad. Herbal Drugs 16: 665-667
14. John, M. M., Marc, A. P. (2002) New therapeutic options in congestive heart failure: Part I. Circulation 105: 2099-2106
15. Kinugawa, S., Tsutsui, H., Hayashidani, S., Ide, T., Suematsu, N., Satoh, S., Utsumi, H., Takeshita, A. (2000) Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: role of oxidative stress. Circ. Res. 87: 392-398
16. Kobayashi, N., Horinaka, S., Mita, S., Yoshida, K., Honda, T., Kobayashi, T., Hara, K., Nishikimi, T., Matsuoka, H. (2002) Aminoguanidine inhibits mitogen activated protein kinase and improves cardiac performance and cardiovascular remodeling in failing hearts of salt-sensitive hypertensive rats. J. Hypertens. 20: 2355-2356
17. Kou, Q. A., Chen, K. Y., Tu, X. H. (2006) Clinical study of safflor yellow injection in treatment of patient with coronary heart disease and angina pectoris. Trad. Chin. Drug Res. Clin. Pharmacol. 17: 294-296
18. Li, X. Z., Liu, J. X., Shang, X. H., Fu, J. H. (2006) Protective effects of hydroxysafflor yellow A on acute myocardial ischemia in dogs. Chin. Pharmacol. Bull. 22: 537-542
19. Liang, X. T. (2004) Basic study of common Chinese medicine, Part II. Science 102-115
20. Liu, F., Wei, Y., Yang, X. Z., Li, F. G., Hu, J., Cheng, R. F. (1992) Hypotensive effects of safflower yellow in spontaneously hypertensive rats and influence on plasma renin activity and angiotensin II level. Acta Pharm Sin 27: 785-787
21. Maki, T., Nasa, Y., Yamaguchi, F., Yoshida, H., Mori, M., Takada, T., Horikawa, E., Okano, K., Takeo, S. (2001) Long-term treatment with neutral endopeptidase inhibitor improves cardiac function and reduces natriuretic peptides in rats with chronic heart failure. Cardiovasc. Res. 51: 608-617
22. Mason, R. B., Pluta, R. M., Walbridge, S., Wink, D. A., Oldfield, E. H., Boock, R. J. (2000) Production of reactive oxygen species after reperfusion in vitro and in vivo. J. Neurosurg. 93: 99-107
23. 2+ antagonistic activity of tinctormine. Pharm. Bull. 41: 1796-1802
24. Miller, A. B., Srivastava, P. (2001) Angiotensin receptor blockers and aldosterone antagonists in chronic heart failure. Cardiol. Clin. 19: 195-202
25. Morgan, E. E., Faulx, M. D., McElfresh, T. A., Kung, T. A., Zawaneh, M. S., Stanley, W. C., Chandler, M. P., Hoit, B. D. (2004) Validation of echocardiography methods for assessing left ventricular dysfunction in rats with myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 287: H2049-H2053
26. Nakamura, R., Egashira, K., Machida, Y., Hayashidani, S., Takeya, M., Utsumi, H., Tsutsui, H., Takeshita, A. (2002) Probucol attenuates left ventricular dysfunction and remolding in tachycardia-induced heart failure: role of oxidative stress and inflammation. Circulation 106: 362-367
27. Okere, I. C., Young, M. E., McElfresh, T. A., Chess D. J., Sharov, V. G., Sabbah, H. N., Hoit, B. D., Ernsberger, P., Chandler, M. P., Stanley, W. C. (2006) Low carbohydrate/high-fat diet attenuates cardiac hypertrophy, remodeling, and altered gene expression in hypertension. Hypertension 48: 1116-1123
28. Pu, Y., Jin, M. (2005) Study of hydroxysafflower yellow A improves myocardial ischemia. Chin. Herbal Med. 35: 374-475
29. Saavedra, W. F., Paolocci, N., John, M. E., Skaf, M. W., Stewart, G. C., Xie, J. S., Harrison, R. W., Zeichner, J., Mudrick, D., Marban, E., Kass, D. A., Hare, J. M. (2002) Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart. Circ. Res. 90: 297-304
30. Sandmann, S., Spitznagel, H., Chung, O., Xia, Q. G., Illner, S., Janichen, G., Rossius, B., Daemen, M. J., Unger, T. (1998) Effects of the calcium channel mibefradil on haemodynamic and morphological parameters in myocardial infarction-induced cardiac failure. Cardiovasc. Res. 39: 339-350
31. Shan, H. L., Yang, B. F., Li, Y. H., Li, Y. R., Xu, C. Q. (2004) Effect of safflower yellow A pigment on abnormal electrophysiology of cardiac myocytes induced by oxygen-derived free radical. Chin. J. Clin. Rehabil. 25: 243-246
32. Sia, Y. T., Lapointe, N., Parker, T. G., Tosporis, J. N., Deschepper, C. F., Calderone, A., Pourdjabbar, A., Jasmin, J. F., Sarrazin, J. F., Liu, P., Adam, A., Butany, J., Rouleau, J. L. (2002) Beneficial effects of long-term use of the antioxidant probucol in heart failure in the rat. Circulation 105: 2549-2555
33. Soeki, T., Kishimoto, I., Okumura, H., Tokudome, T., Horio, T., Mori, K., Kangawa, K. (2005) C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction. J. Am. Coll. Cardiol. 45: 608-616
34. Song, Y., Zhang, L., Qu, K., Li, C., Zhu, H. B. (2005) Hydroxysafflor yellow A promotes vascular endothelial cell proliferation via VEGF/VEGF receptor. J. Chin. Pharm. Sci. 14: 181-185
35. Stanton, L. W., Garrard, L. J., Damm, D., Garrick, B. L., Lam, A., Kapoun, A. M., Zheng, Q., Protter, A. A., Schreiner, G. F., White, R. T. (2000) Altered patterns of gene expression in response to myocardial infarction. Circ. Res. 86: 939-945
36. Takimoto, Y., Aoyama, T., Keyamura, R., Shinoda, E., Hattori, R., Yui, Y., Sasayama, S. (2000) Differential expression of three types of nitric oxide synthase in both infarcted and non-infarcted left ventricles after myocardial infarction in the rat. Int. J. Cardiol. 76: 135-145
37. Tian, J., Jang, W., Wang, Z., Wang, C., Fu, F. (2003) Effects of safflower flavone on local cerebral ischemia and thrombosis formation in rats. Chin. Trad. Herb Drugs 34: 741-743
38. Wang, Y. P., Qiao, J., Qian, Z. X. (1995) Studies on effect of safflower to protect ischemia of myocardium and antioxidation. Chin. J. Thorac. Cardiovasc. Surg. 11: 176-179
39. Wei, X. B., Liu, H. Q., Sun, X., Fu, F. H., Zhang, X. M., Wang, J., An, J., Ding, H. (2005) Hydroxysafflor yellow A protects rat brains against ischemia-reperfusion injury by antioxidant action. Neurosci. Lett. 386: 58-62
40. Xiao, W. Y. (2006) Investigative progress of safflor yellow. Proc. Clin. Med. J. 15: 646-649
41. Xu, C. H., Zhang, S. F., Ma, E. M. (2005) Protective effect of safflor yellow A on myocardial ischemical reperfusion injury of rats. Chin. J. Clin. Rehabil. 43: 93-95
42. Zang, B., Jin, M., Si, N., Zhang, Y., Wu, W., Piao, Y. (2002) Platelet activating factor receptor binding can be antagonized by HSYA. Acta Pharm. Sin. 37: 696-699
43. Zheng, Z. B., Liu, J. G., Guan, F. Y. (2000) Effect of safflower yellow A on myocardial ischemia in dogs. China Pharmacol. Report 16: 590-592
44. Zheng, Z. B., Zheng, W. C., Zhao, H. (2003) Protective effect of safflor yellow A on myocardial ischemical reperfusion injury of rats. China Trad. Chin. Med. Technol. 10: 290-293
45. Zheng, W. C., Zheng, Z. B., Zhang, L. (2005a) Protective experimental study of safflower yellow A on acute myocardial ischemia in rats induced by hypophysin. China Trad. Chin. Med. Technol. 12: 36-38
46. Zheng, W. C., Chen, D. B., Zhang, L., Li, B. (2005b) The effects and mechanism of safflor yellow A on myocardial ischemia. Chin. Pharmacol. Bull. 21: 978-980